New Product Ranges, Training Events, Training Workshops, Uncategorised
Upcoming Course: Botulinum Toxin masterclass
Jul
Course: Botulinum Toxin Masterclass
Lecturer: Prof Syed Haq
Location: John Bannon Pharma Dublin
Date: July 27th 10.30am/1.30pm (places limited)
Masterclass covers:
- Dilutions of all toxins
- Botox
- Azzalure
- Dysport
- Bocotoure
- Comparing all toxins
- Best practice and advanced techniques
Cost: €275+vat for John Bannon customers
Contact: Ciaran@johnbannon.ie to register
About Professor Haq:
Professor Syed Haq, MBBS BSc PhD DIC MRCP(UK) is a Consultant Physician and Founder of Invictus Humanus. He is currently the Chief Medical and Scientific Officer of a UK ABPI registered biopharmaceutical company developing a platform for the treatment of Alzheimer’s disease. To date he has co-ordinated and overseen the successful completion of two MHRA registered phase IIa double blind placebo controlled clinical trials undertaken in the UK. He notably achieved the successful award of an Orphan Drug Designation in the indication of Systemic Sclerosis from the United States Federal Drug and Food Administration (USFDA) in 2014. Prof. Haq has worked closely with PwC and Rothschilds in the past, as part of a biopharma valuation process. Prof. Haq trained at Guy’s Hospital, Hammersmith and the Royal Brompton Hospitals, Imperial College University, Massachusetts General Hospital, Harvard Medical School, and Tufts University in Boston. Prof. Haq has published over 100 peer-reviewed scientific articles/abstracts in e.g., Journal of Clinical Investigations, Proceedings of the National Academy of Science, Ann Rheum Diseases, Arthritis Research and Therapy and Nature Medicine. He has received multiple national and international awards/fellowships/honours from the Medical Research Council, Wellcome Trust, Zeneca Pharmaceuticals, American Heart Association, Heart Failure Society of America. He was the Chairman and a co-founder of the Association of PDO Threads UK and currently acts as a key opinion leader for several companies including Galderma, Ipsen and is a member of the editorial board of Body Language. Alzheimer’s Disease International in conjunction with ITN recently interviewed Prof Haq regarding a therapeutic he has developed in AD.
Prof Haq acted as an External Adviser for Course Approval for the MSc in Non Surgical Facial Aesthetics for Dentists, University of Central Lancashire.
